diabetes mellitus
Conditions
Interventions
APP Group:Non-endocrine specialists use smartphone applications to adjust insulin glargine doses in combination with clinical realities
Conventional therapy Group:Non-endocrinologists adjust the dose of insulin glargine in real time based on their own experience and clinical conditions
Sponsors
Binhai Central Hospital, Dongguan City
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with type 2 diabetes who meet the 1999 World Health Organization (WHO) diagnostic criteria for diabetes ; 2. The indications for insulin use are consistent with the 7th edition of Internal Medicine issued by People's Health Publishing House; 3. Sign consent to participate in the study after explanation.
Exclusion criteria
Exclusion criteria: 1. Type 1 diabetes or gestational diabetes or secondary diabetes; 2. Acute diabetic complications such as ketoacidosis, hypertonic coma and lactic acidosis; 3. Severe liver insufficiency, renal insufficiency(eGFR<60mL?min-1?1.73m-2),malignancy,acute cardiovascular and/or cerebrovascular diseases, severe hematological disease, severe autoimmune disease; 4. Psychosis; 5. Unable to eat normally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| body height;body weight;fasting blood glucose;fasting C peptide;triglyceride;high density lipoprotein cholesterol;target days; | — |
Secondary
| Measure | Time frame |
|---|---|
| glycosylated hemoglobin;total cholesterol;low density lipoprotein cholesterin;creatinine;liver enzyme;blood pressure;age;sex; | — |
Countries
China
Contacts
Public ContactEnsi LUO
Endocrinology department, Binhai Central Hospital, Dongguan City
Outcome results
None listed